| CYHS0600186 | 三磷酸腺苷二钠-氯化镁注射液 | Adenosine Disodium Triphosphate;Magnesium chloride | Injection | Chemical Drugs(6) | Generic Drug | 2006-04-28 | 齐齐哈尔第二制药有限公司 | Qiqiha'er No2 Pharmaceutical Factory | Certificate Issued | 2009-06-11 | view |
| CXHL1300362 | QLNC-3A6二马来酸盐 | QLNC-3A6 | Other | Chemical Drugs(1.1) | New Drug Application | 2013-06-24 | 齐鲁安替（临邑）制药有限公司 | Shandong Anhong Pharmaceutical Co Ltd | Certificate Issued | 2014-03-04 | view |
| CXSL1100066 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(15) | New Drug Application | 2011-12-08 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2013-09-13 | view |
| CXHL1600120 | WX-0593片 | iruplinalkib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-12-15 | view |
| CXSB0500008 | 注射用重组人白介素－11 | recombinant human interleukin-11 | Lyophilized | Biological Products | Supplementary Application | 2005-02-26 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | In Review | 2005-02-22 | view |
| CYSB1100109 | 注射用重组人白介素-11 | recombinant human interleukin-11 | Lyophilized | Biological Products | Supplementary Application | 2011-03-09 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2011-06-16 | view |
| CXHL1300363 | QLNC-3A6二马来酸盐片 | QLNC-3A6 | Tablet | Chemical Drugs(1.1) | New Drug Application | 2013-06-24 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2014-03-04 | view |
| CXSL1300088 | 重组抗TNFα全人单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-12-11 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-06-27 | view |
| CXSL1300074 | 注射用重组人血小板生成素拟肽-Fc融合蛋白 | | | Biological Products(7) | New Drug Application | 2013-11-01 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-03-25 | view |
| CXHL1600116 | WX-0593片 | iruplinalkib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-12-15 | view |
| CXSL1300075 | 注射用重组人血小板生成素拟肽-Fc融合蛋白 | | | Biological Products(7) | New Drug Application | 2013-11-01 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-03-25 | view |
| CYSB1100110 | 注射用重组人白介素-11 | recombinant human interleukin-11 | Lyophilized | Biological Products | Supplementary Application | 2011-03-09 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2011-06-16 | view |
| CYSB1100111 | 注射用重组人白介素-11 | recombinant human interleukin-11 | Lyophilized | Biological Products | Supplementary Application | 2011-03-09 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2011-06-16 | view |
| CXHL1600115 | WX-0593 | iruplinalkib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL1300087 | 重组抗TNFα全人单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-12-02 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-06-27 | view |
| CXHL1600119 | WX-0593片 | iruplinalkib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2016-05-13 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2016-12-15 | view |
| CXSL1600103 | 注射用重组抗HER2人源化单克隆抗体-DM1 | recombinant humanized anti-HER2 mAb-DM1 | Lyophilized | Biological Products(1) | New Drug Application | 2017-01-05 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2017-09-27 | view |
| CXSL1100055 | 重组人血清白蛋白-干扰素α2a融合蛋白注射液(酵母) | | Injection | Biological Products(1) | New Drug Application | 2011-09-26 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2013-09-13 | view |
| CXHL1300364 | QLNC-3A6二马来酸盐片 | QLNC-3A6 | Tablet | Chemical Drugs(1.1) | New Drug Application | 2013-06-24 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2014-03-04 | view |
| X0408089 | 注射用重组人白介素－11 | recombinant human interleukin-11 | Lyophilized | Biological Products | Supplementary Application | 2005-01-04 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2005-06-17 | view |
